CCR5 and HIV infectious disease: Looking at the desirable effects, CCR5Δ32 protects against HIV infection, since the homozygous state of the variant impairs the proper expression of CCR5, preventing the interaction of CCR5 (the main HIV co-receptor) with the virus on the cell surface, thus avoiding infection of the host (75, 76).